These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
3. Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Engel J; Kerr J; Eckel R; Günther B; Heiss M; Heitland W; Siewert JR; Jauch KW; Hölzel D Eur J Surg Oncol; 2005 Jun; 31(5):512-20. PubMed ID: 15878259 [TBL] [Abstract][Full Text] [Related]
4. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Wibe A; Syse A; Andersen E; Tretli S; Myrvold HE; Søreide O; Dis Colon Rectum; 2004 Jan; 47(1):48-58. PubMed ID: 14719151 [TBL] [Abstract][Full Text] [Related]
5. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy. Law WL; Ho JW; Chan R; Au G; Chu KW Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860 [TBL] [Abstract][Full Text] [Related]
6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
7. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; McCollum AD; Brady D; O'Connell MJ; Mayer RJ; Cummings B; Willett C; Macdonald JS; Benson AB; Fuchs CS J Clin Oncol; 2004 Feb; 22(4):648-57. PubMed ID: 14966087 [TBL] [Abstract][Full Text] [Related]
8. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501 [TBL] [Abstract][Full Text] [Related]
9. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Madbouly KM; Remzi FH; Erkek BA; Senagore AJ; Baeslach CM; Khandwala F; Fazio VW; Lavery IC Dis Colon Rectum; 2005 Apr; 48(4):711-9; discussion 719-21. PubMed ID: 15768186 [TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes after total mesorectal excision for rectal cancer. Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534 [TBL] [Abstract][Full Text] [Related]
11. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center. Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410 [TBL] [Abstract][Full Text] [Related]
12. Results of long-term follow-up for transanal excision for rectal cancer. Gonzalez QH; Heslin MJ; Shore G; Vickers SM; Urist MM; Bland KI Am Surg; 2003 Aug; 69(8):675-8; discussion 678. PubMed ID: 12953825 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423 [TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer. Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464 [TBL] [Abstract][Full Text] [Related]
16. Transanal local wide excision for rectal adenocarcinoma. Chen CC; Leu SY; Liu MC; Jian JJ; Chen CM Hepatogastroenterology; 2005; 52(62):460-3. PubMed ID: 15816457 [TBL] [Abstract][Full Text] [Related]
17. Patient and hospital factors associated with use of sphincter-sparing surgery for rectal cancer. Paquette IM; Kemp JA; Finlayson SR Dis Colon Rectum; 2010 Feb; 53(2):115-20. PubMed ID: 20087084 [TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]
19. Use of smooth muscle plasty after intersphincteric rectal resection to replace a partially resected internal anal sphincter: long-term follow-up. Krand O; Yalti T; Tellioglu G; Kara M; Berber I; Titiz MI Dis Colon Rectum; 2009 Nov; 52(11):1895-901. PubMed ID: 19966639 [TBL] [Abstract][Full Text] [Related]
20. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]